Skotny A, Gomułka K, Wolańczyk-Mędrala A, Mędrala W. Annexin V binding assay as a basophil activation
test in an allergy to Secale cereale. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2021;38(6):1115-1117. doi:10.5114/ada.2021.112283.
APA
Skotny, A., Gomułka, K., Wolańczyk-Mędrala, A., & Mędrala, W. (2021). Annexin V binding assay as a basophil activation
test in an allergy to Secale cereale. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 38(6), 1115-1117. https://doi.org/10.5114/ada.2021.112283
Chicago
Skotny, Anna, Krzysztof Gomułka, Anna Wolańczyk-Mędrala, and Wojciech Mędrala. 2021. "Annexin V binding assay as a basophil activation
test in an allergy to Secale cereale". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 38 (6): 1115-1117. doi:10.5114/ada.2021.112283.
Harvard
Skotny, A., Gomułka, K., Wolańczyk-Mędrala, A., and Mędrala, W. (2021). Annexin V binding assay as a basophil activation
test in an allergy to Secale cereale. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 38(6), pp.1115-1117. https://doi.org/10.5114/ada.2021.112283
MLA
Skotny, Anna et al. "Annexin V binding assay as a basophil activation
test in an allergy to Secale cereale." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 38, no. 6, 2021, pp. 1115-1117. doi:10.5114/ada.2021.112283.
Vancouver
Skotny A, Gomułka K, Wolańczyk-Mędrala A, Mędrala W. Annexin V binding assay as a basophil activation
test in an allergy to Secale cereale. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2021;38(6):1115-1117. doi:10.5114/ada.2021.112283.
Diagnosis of allergic diseases is a problem that still cannot be easily overcome. An increasing number of studies have investigated achievement of flow cytometry as a very promising and helpful technique as an allergy diagnostic item. Different types of cells’ identification or activation markers and many research protocols have been shown. However there were no reliable trials that could allow to base the clinical decision on those proposed improvements. Annexin V is a cellular protein that is well known as a marker of early apoptosis but only a few papers mention its possible potential for being a marker of basophil activation [1, 2].